Schedule 13G ownership disclosure

BRIDGEBIO PHARMA INC

Security class unavailable · CUSIP: 10806X102

Event date: 2019-07-01

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-19-192463
Form type
SC 13G
Filer
BridgeBio Pharma, Inc.
CIK
CIK 1743881
Filed
Jul 11, 2019
Reporting period
Jul 01, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub